Shkreli's Former Company KaloBios Appeals Nasdaq Delisting

Martin Shkreli Case Holds Mirror to Pharma Business

KaloBios Pharmaceuticals Inc., the biotechnology company formerly led by Martin Shkreli, is appealing the Nasdaq stock market’s decision to delist its shares.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.